Cargando…
A synthetic defective interfering SARS-CoV-2
Viruses thrive by exploiting the cells they infect, but in order to replicate and infect other cells they must produce viral proteins. As a result, viruses are also susceptible to exploitation by defective versions of themselves that do not produce such proteins. A defective viral genome with deleti...
Autores principales: | Yao, Shun, Narayanan, Anoop, Majowicz, Sydney A., Jose, Joyce, Archetti, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255065/ https://www.ncbi.nlm.nih.gov/pubmed/34249513 http://dx.doi.org/10.7717/peerj.11686 |
Ejemplares similares
-
Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
por: Narayanan, Anoop, et al.
Publicado: (2022) -
Evolution of naturally arising SARS-CoV-2 defective interfering particles
por: Girgis, Samer, et al.
Publicado: (2022) -
Recombination between coronaviruses and synthetic RNAs and biorisk implications motivated by a SARS-CoV-2 FCS origin controversy
por: Mueller, Siguna
Publicado: (2023) -
Fighting SARS-CoV-2 with green seaweed Ulva sp. extract: extraction protocol predetermines crude ulvan extract anti-SARS-CoV-2 inhibition properties in in vitro Vero-E6 cells assay
por: Shefer, Shai, et al.
Publicado: (2021) -
Paper-Based Point-of-Care Testing of SARS-CoV-2
por: Jia, Yuan, et al.
Publicado: (2021)